| Bioactivity | (S)-PHA533533 is a cyclin-dependent kinase 2 (CDK2) inhibitor. (S)-PHA533533 shows anti-tumor activity and can induce widespread neuronal UBE3A expression in angelman syndrome model mice[1]. |
| CAS | 437982-89-3 |
| Formula | C19H22N4O2 |
| Molar Mass | 338.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Vihma H, et al. Ube3a unsilencer for the potential treatment of Angelman syndrome. Nat Commun. 2024 Jul 8;15(1):5558. |
(S)-PHA533533
CAS: 437982-89-3 F: C19H22N4O2 W: 338.40
(S)-PHA533533 is a cyclin-dependent kinase 2 (CDK2) inhibitor. (S)-PHA533533 shows anti-tumor activity and can induce wi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.